The pharmaceutical industry is undergoing a transformation, driven by the integration of advanced technologies such as artificial intelligence (AI) and quantum computing. Sanofi, a major player in the sector, exemplifies the growing importance of AI in drug research and development (R&D). Recently, Eli Lilly has also increased its investments in AI, highlighting a sector-wide trend towards optimizing drug discovery processes. However, these technological advancements come with significant regulatory and ethical challenges, necessitating a rapid adaptation of existing frameworks.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
